GDP/EU-GMP German medical cannabis importer, manufacturer, and wholesaler seeks strategic partner
Prominent German pharmaceutical cannabis wholesaler and manufacturer, operating an asset-light model, seeks €1 million investment to expand into telehealth and drive further growth. With a strong track record in GMP-certified production and distribution, this company is poised for significant advancement and offers a unique opportunity for strategic partnership.
Listing ID:
22327924509
Licence(s) Held:
GDP Distribution Licence, EU-GMP Certification (Product Release), MedCanG Cannabis License, Wholesale License for Active Substances Used in Medicinal Products
Seeking strategic equity partner to invest €1 million for continued growth and expansion
Listing Details:
Established German cannabis importer, manufacturer, and wholesaler of pharmaceutical-grade medical cannabis products, adhering to GDP and EU-GMP standards
Built as an asset-light model, outsourcing warehousing and logistics to a seasoned pharmaceutical logistics partner
Offers unique products with a dedicated customer base, the company benefits from a skilled sales team and strategic partnerships with major global cannabis market players
Imports high-quality products from cultivators and partners with extraction facilities in Portugal, Spain, Denmark, and Canada, while ensuring swift market entry through regulatory expertise
With over 700 pharmacies served and substantial growth since April, the company plans to expand into new markets like Portugal through joint ventures with local cultivators
In 2023, the company generated over €800k in revenue, with forecasts indicating a rise to €1.5 million by the end of 2024 and achieving profitability by Q1 2025
Established supply agreements/contracts in place with major players in the global cannabis market
Company is developing a telemedicine platform to boost market reach and profitability, with anticipated financial benefits in 2025
Seeks strategic equity partner to invest €1 million to facilitate product introduction, secure exclusive contracts, expand sales, and enter the Portuguese market
Company is valued at $5 million pre-investment and is open to discussions for a majority takeover of 51%+ ownership
22327924509